Ohio Hits Over $3B in Total Cannabis Sales

COLUMBUS – Ohio’s legal Cannabis market has generated $3.56 billion in combined medical and recreational sales through the end of February, driven by steady growth in both segments since adult-use purchases became legal in August 2024.

The Division of Cannabis Control reported total product sales of $3.569 billion as of February 28, with adult-use accounting for $1.247 billion and medical sales reaching $2.322 billion. This marks a significant milestone for the state, where medical Cannabis has been available since 2019, now supplemented by a robust recreational market.

Transaction volumes reflect strong consumer interest, with 38.68 million total receipts recorded: 17.94 million from adult-use and 20.74 million from medical. Average prices during the last week of February held at $17.80 per one-tenth ounce of plant material, or $6.29 per gram, and $24.53 for manufactured products, indicating a competitive environment as supply chains mature. Plant material sold to adult-use customers represents roughly 37% of the statewide total by weight; manufactured units sit near 41%.

Recreational demand is accelerating overall growth, while the medical market remains a core revenue driver, serving 467,085 registered patients as of late January.

The infrastructure supporting the sales includes 37 dual-use cultivators, 45 processors, six testing labs, and 204 dispensaries operating under dual licenses. Earlier reports showed sales climbing steadily: through mid-February, totals stood at $3.52 billion, with adult-use at $1.21 billion. By late January, recreational sales alone had exceeded $1.1 billion since launch.

Ohio’s regulated Cannabis sector has reached a point of measurable economic weight, with medical and adult-use channels each carving out distinct but overlapping roles. This pattern indicates widening consumer participation beyond the established medical patient base and supports the prospect of more balanced segment contributions over time. Stable pricing and expanded licensing point to operational efficiency, though ongoing supply chain refinements will determine if the state can maintain this momentum against nationwide competition.

Photo: inquirer.com/Philly420